Daily Respiratory Research Analysis
Analyzed 114 papers and selected 3 impactful papers.
Summary
Mechanistic and population-level advances span respiratory oncology, infectious disease control, and neonatal respiratory outcomes. A Cell Reports study reveals a SIRT5–FDX1 axis driving cuproptosis resistance in lung adenocarcinoma and a combinatorial therapeutic strategy. Public health investigators link residential water heaters to Legionnaires' disease clusters, while a large multicenter cohort clarifies how the timing of preterm membrane rupture shapes survival and bronchopulmonary morbidity.
Research Themes
- Cuproptosis resistance mechanisms and therapeutic targeting in lung adenocarcinoma
- Built-environment drivers of Legionnaires' disease and outbreak source control
- Perinatal determinants of bronchopulmonary outcomes in extreme prematurity
Selected Articles
1. SIRT5-mediated FDX1 desuccinylation confers cuproptosis resistance in lung adenocarcinoma.
This preclinical study identifies a SIRT5–FDX1 post-translational pathway that degrades a key cuproptosis effector and enables lung adenocarcinoma resistance. Pharmacologic SIRT5 inhibition synergized with a copper ionophore (Elesclomol-Cu) to suppress tumor growth in vivo, nominating a tractable combination strategy.
Impact: Reveals a first-in-kind desuccinylation-driven resistance mechanism and provides an immediately actionable therapeutic combination with in vivo efficacy.
Clinical Implications: Suggests biomarker-driven trials of SIRT5 inhibition plus cuproptosis inducers in lung adenocarcinoma, and assessment of FDX1 succinylation/abundance as predictors of response.
Key Findings
- Copper stress upregulates SIRT5 and reduces global protein succinylation in LUAD cells.
- SIRT5 desuccinylates FDX1 at Lys84, triggering TRIM8-mediated ubiquitination and proteasomal degradation.
- SIRT5 inhibitor MC3482 plus Elesclomol-Cu synergistically suppresses LUAD tumor growth in vivo.
Methodological Strengths
- Multi-modal mechanistic interrogation (post-translational modification mapping, ubiquitination assays, and functional validation).
- In vivo efficacy demonstration of a rational drug combination.
Limitations
- Preclinical models; absence of human interventional data.
- Safety, pharmacokinetics, and optimal dosing of SIRT5 inhibitors in humans remain undefined.
Future Directions: Translate to early-phase trials with patient stratification by SIRT5/FDX1 status and copper homeostasis; explore resistance evolution under combination therapy.
Cuproptosis, a copper-dependent cell death process induced by excessive copper, represents an emerging therapeutic strategy in oncology. However, tumor-specific molecular pathways regulating this process remain poorly defined. Here, we demonstrate that copper levels are elevated in lung adenocarcinoma (LUAD), and LUAD cell lines exhibit increased resistance to cuproptosis. Mechanistically, elevated copper stress promotes the expression of the desuccinylase SIRT5 while reducing global succinylation in LUAD cells. Furthermore, we found that SIRT5 is a critical mediator of cuproptosis through the desuccinylation modification on ferredoxin1 (FDX1) protein at Lys84. This modification triggers TRIM8-mediated ubiquitination, leading to FDX1 proteasomal degradation and enhanced cuproptosis resistance. These results reveal the important role of SIRT5 in LUAD cuproptosis resistance. Notably, combining the SIRT5 inhibitor MC3482 with the cuproptosis inducer Elesclomol-Cu synergistically suppresses tumor growth in vivo, suggesting a promising therapeutic strategy. These findings elucidate mechanisms underlying cuproptosis resistance and propose a novel treatment approach for LUAD.
2. Outbreak of Legionnaires' Disease Linked to Newly Installed Residential Water Heaters, the Netherlands, 2022-2023.
Two apartment-building clusters of Legionnaires’ disease were traced to newly installed residential water heaters, with environmental L. pneumophila ST37 matching clinical isolates. In a case-control analysis, recent installation of a specific heater brand conferred an extraordinary risk (OR 542), prompting manufacturer remediation.
Impact: Provides strong epidemiologic and molecular evidence implicating consumer water heaters as LD sources, with immediate implications for product design, installation, and surveillance.
Clinical Implications: Clinicians should consider domestic water heaters as potential LD sources in sporadic/clustered cases; public health actions include risk communication, heater disinfection/retrofit, and targeted environmental testing within 6 months of installation.
Key Findings
- Two residential LD clusters were associated with newly installed brand A water heaters.
- Environmental L. pneumophila serogroup 1 ST37 matched a clinical isolate, supporting source attribution.
- Case-control analysis showed a very strong association (OR 542; 95% CI 24.76–11,854.03); manufacturer implemented control measures.
Methodological Strengths
- Integration of molecular typing (ST matching) with analytic epidemiology (case-control).
- Clear exposure window definition (<6 months post-installation) enhances causal inference.
Limitations
- Small absolute number of cases limits precision and generalizability.
- Unmeasured confounding in control selection cannot be fully excluded.
Future Directions: Design audits and engineering controls for implicated heater models; proactive surveillance of residential hot-water systems after installation; risk-modeling to inform building codes.
During 2022-2023, two small Legionnaires' disease (LD) clusters (2 and 4 cases) occurred in 2 residential apartment buildings in the Netherlands. All case-patients recently installed a new brand A water heater. Environmental sampling revealed Legionella pneumophila serogroup 1 sequence type 37 in the hot water system of each case-patient's apartment, matching 1 clinical isolate. We conducted a case-control study to evaluate whether brand A water heaters were linked to cases in the 2 clusters. We identified 23 LD case-patients, 21 of whom had a brand A water heater installed <6 months before illness onset. Four cases had a genotypic match between clinical and environmental isolates; none of 31 control-patients had recently installed a water heater. Analyses showed that LD cases were strongly associated with new brand A water heaters (OR 542 [95% CI 24.76-11,854.03]); the manufacturer implemented control measures. Residential water heaters could serve as L. pneumophila transmission sources.
3. Rupture of membranes and short-term respiratory outcomes in extremely preterm infants: a multicenter retrospective cohort study.
In 4,954 extremely preterm infants (23–27+6 weeks), higher gestational age at ROM increased survival and survival without BPD while lowering pneumothorax risk; longer latency from ROM to delivery had the opposite effects. These real-world, multicenter data refine perinatal counseling and risk stratification.
Impact: Provides high-quality, multicenter evidence quantifying how ROM timing and latency shape survival and bronchopulmonary morbidity in extremely preterm infants.
Clinical Implications: Incorporate gestational age at ROM and ROM-to-delivery latency into individualized prognostic discussions and perinatal management to mitigate pneumothorax and optimize survival without BPD.
Key Findings
- Among 4,954 extremely preterm infants, 37.1% had ROM ≥24 hours before delivery.
- Higher gestational age at ROM increased survival (aOR 1.10) and survival without BPD (aOR 1.11) and reduced pneumothorax risk (aOR 0.91).
- Longer ROM-to-delivery latency decreased survival (aOR 0.92) and survival without BPD (aOR 0.89) and increased pneumothorax risk (aOR 1.07).
Methodological Strengths
- Large, multicenter cohort with clearly defined exposure windows and adjusted analyses.
- Clinically meaningful composite endpoint (survival without BPD) plus specific complications (pneumothorax).
Limitations
- Observational design limits causal inference; residual confounding possible.
- Potential variability in ROM ascertainment and perinatal practices across centers.
Future Directions: Develop risk calculators incorporating ROM timing and latency; test perinatal interventions aimed at minimizing harmful latency while optimizing neonatal respiratory outcomes.
BACKGROUND: We aimed to describe the epidemiology and outcomes of preterm premature rupture of membranes (PPROM) in extremely preterm infants, and to analyze the impact of the timing of rupture of membranes (ROM) on survival and short-term respiratory outcomes. METHODS: Observational, multi-center cohort study, including extremely preterm infants born between 23 + 0 and 27 + 6 weeks. Gestational age at ROM and time interval from ROM to birth were the main exposure variables, the primary outcome was survival without BPD. RESULTS: The study included 4954 infants, median gestational age was 26 weeks (IQR 25-27). Overall, 1974 infants (37.1%) had rupture of membranes 24 or more hours prior to delivery. Higher gestational age at ROM was associated with increased survival (aOR 1.10, 95%CI 1.05-1.16), increased survival without BPD (aOR 1.11, 95%CI 1.04-1.20), and decreased risk of pneumothorax (aOR 0.91, 95%CI 0.84-0.97). Longer time from ROM to delivery was associated with decreased survival (aOR 0.92, 95%CI 0.87-0.96), decreased survival without BPD (aOR 0.89, 95% CI 0.83-0.96), and pneumothorax (aOR 1.07, 95%CI 1.02-1.12). CONCLUSION: Earlier timing of rupture of membranes and longer interval between ROM and birth impact survival and survival without BPD. Both factors should be considered when counseling families at risk of preterm birth. IMPACT: The timing of ROM has an impact on short term outcomes and respiratory morbidity in extremely preterm infants, and it should be taken into consideration when counseling families. This large, multicentre study including over 4954 infants provides real-world data on how earlier gestational age at ROM and prolonged latency to delivery are associated with worse outcomes in extremely preterm infants. The findings have important clinical implications for perinatal decision-making and family counseling, helping shape individualized risk assessments and guide perinatal interventions.